Meeting
2020 ASCO Virtual Scientific Program
Circulating tumor DNA dynamics to predict cancer recurrence/metastasis in Chinese pathologic stage I lung adenocarcinoma.
Authors
Chao Cheng
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Chao Cheng , Weixiong Yang , Na You , Minghan Jia , Sai-Ching Yeung , Man Yu , Yinguang Wang , Xiayu Fu , Zhenguo Liu , Bo Zeng , Qiuxiang Ou , Xue Wu , Yang Shao , Siyu Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Clinical Trial Registration Number
NCT03172156
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3537)
DOI
10.1200/JCO.2020.38.15_suppl.3537
Abstract #
3537
Poster Bd #
267
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Minimal residual disease (MRD) in patients with resected stage I NSCLC: Results of the prospective adjuvant IFCT-0703 trial.
First Author: Damien Vasseur
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel.
First Author: Noa Ben-Baruch
Poster
2022 ASCO Annual Meeting
Novel use of ctDNA to identify muscle-invasive and non-organ-confined upper tract urothelial carcinoma.
First Author: Heather L Huelster
Poster
2022 ASCO Annual Meeting
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.
First Author: Michael David Kinnaman